v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash Flows From Operating Activities:          
Net (loss) income $ (2,773) $ 1,990 $ (6,391) $ 1,722  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     455 646  
Loss on disposition of assets     9 0  
Share-based compensation     3,073 1,814  
Warranty provision     42 (37)  
Change in fair value of warrant liabilities 0 (5,600) (3,158) (12,517)  
Non-cash lease expense     (278) 217  
Provision for doubtful accounts     35 (89)  
Inventory obsolescence reserve     (397) 12  
Changes in assets and liabilities:          
Accounts receivable     (1,344) 2,337  
Inventories     1,106 (529)  
Prepaid expenses and other current assets     (156) 666  
Accounts payable     (13) 168  
Operating lease liability     295 (99)  
Customer deposits     34 (956)  
Accrued liabilities and other     (876) (370)  
Warranty settlement     (13) (42)  
Deferred revenue     (105) 130  
Changes in other non-current assets     58 8  
Net cash used in operating activities     (7,624) (6,919)  
Cash Flows From Investing Activities:          
Proceeds from maturities of short-term investments     0 7,500  
Capital expenditures for property and equipment     (93) (13)  
Investment in patents and trademarks     (156) (124)  
Net cash (used in) provided by investing activities     (249) 7,363  
Cash Flows From Financing Activities:          
Proceeds from exercise of stock options     0 588  
Proceeds from issuance of Series B Convertible Preferred Stock     4,500 0  
Proceeds from issuance of warrants and common stock, net of offering costs     5,728 0  
Dividends settled in Cash     0 (120)  
Net cash provided by financing activities     10,228 468  
Net increase in cash and cash equivalents     2,355 912  
Cash and cash equivalents, beginning of period     3,610 3,955 $ 3,955
Cash and cash equivalents, end of period $ 5,965 $ 4,867 5,965 4,867 $ 3,610
Supplemental Disclosure of Non-Cash Investing and Financing Activities:          
Reclassification of warrant liabilities to additional paid in capital     12,151 94  
Dividends on convertible preferred stock     (492) (1,017)  
Dividends settled with common stock     $ 492 $ 140  

Source